Zappy Health / Ousia Pharmacy

Overview

Zappy Health marketed compounded wellness and weight-related products online while fulfillment ran through Ousia Pharmacy. NPR correspondent Sydney Lupkin’s pharmaceuticals reporting examined whether the pharmacy held the sterile compounding authority required for what patients were receiving — a basic licensing question that is easy to miss on a sleek telehealth storefront.

The public story is less about one brand’s branding kit and more about a supply-chain pattern: consumers believe they are buying from a compliant sterile pharmacy pathway, then later learn the licensing picture was incomplete or contested. When pressure arrived, the pharmacy’s license position changed — including relinquishment — which is a measurable public outcome.

For this desk, Zappy / Ousia is a reference case for “pharmacy-of-record literacy”: what state authority was claimed, what was required for sterile injectable work, and how quickly that story changes once specialists (and journalists) pull board records.

Why we track it. Clear public example of sterile-authority mismatch between telehealth marketing and the compounding pharmacy patients actually rely on.

Tracked public case — pharmacy licensing and sterile-scope pattern brief for partners comparing telehealth fulfillment chains.

Public record timeline

1. Coverage period

   NPR examines sterile compounding authority for the Ousia / Zappy fulfillment path

2. Regulatory response

   Pharmacy license position changes under scrutiny, including relinquishment reporting